WHO WE SERVE
The innovators shaping healthcare
We partner with healthcare leaders and innovators who want to make sure their big ideas find an audience. Whether you have a new medical device or a message that will change public health outcomes, we help build the evidence and the go to market strategy that drives adoption.
ONE
Non-US early-stage device founders
The Challenge:
You’ve got a validated product and a plan to enter the world’s largest healthcare market — but the US system runs on rules you didn’t write: FDA pathways, payer dynamics, coding, coverage. The costliest mistakes happen early, when you’re generating evidence for the wrong audience.
How We Help:
We tell you what evidence the US market will demand before you spend to generate it — then help you build the market case around it. You enter with a roadmap, not a guess.
What It Looks Like:
03.
Evidence Strategy
Review
04.
Business
Plan
02.
Market
Landscape
01.
Founder’s
Workshop
TWO
Healthcare & device VCs
The Challenge:
Every deal looks promising in the pitch. The question you need to answer before you commit is whether it’s clinically feasible, regulable, and reimbursable.
How We Help:
We pressure-test the evidence and the regulatory logic behind a venture, so your diligence rests on what the FDA, CMS, and payers will actually require — not on the founder’s optimism.
What It Looks Like:
03.
Evidence & Regulatory Assessment
04.
Industry Analysis
02.
Pitch & Diligence Review
01.
VC
Advisory
THREE
Non-US & US device scale-ups
The Challenge:
You’ve got early traction. Now you need durable US growth — coverage locked, positioning sharp, go-to-market real.
How We Help:
We connect the dots between evidence, coverage, and commercial story so your growth compounds instead of stalling at the next payer or the next market.
What It Looks Like:
02.
Regulatory & Reimbursement Review
04.
Industry Analysis
03.
Evidence & Regulatory Assessment
01.
Market Landscape
FOUR
Large device manufacturers
The Challenge:
Across a complex portfolio, evidence and coverage strategy drift out of sync so even strong clinical data underperforms as a market narrative.
How We Help:
We align evidence and coverage strategy across products and sharpen the clinical story so it persuades as well as it complies — one evidence base, working everywhere.
What It Looks Like:
02.
Regulatory & Reimbursement Review
01.
Evidence Strategy Review
04.
Custom Consulting
03.
KOL
Visibility
FIVE
U.S. healthcare services companies
The Challenge:
You’ve got proven traction. What’s holding you back is positioning, messaging, and a go-to-market motion built to scale.
How We Help:
We ground your positioning in evidence and outcomes, not slogans, so growth-stage messaging earns trust with the clinical and enterprise buyers who matter.
What It Looks Like:
01.
GTM For Healthcare Companies
03.
Marketing
Strategy
02.
Positioning & Messaging
SIX
Advertisers & communications firms serving public health
The Challenge:
You’re accountable for public health campaigns that have to change real behavior and stand up to clinical and community scrutiny.
How We Help:
We supply the evidence base and clinical validation your creative is built on, so campaigns are accurate, persuasive, and measurable against health outcomes. You bring the reach; we make sure it’s grounded.
What It Looks Like:
01.
Public Health Campaign Strategy
03.
KPI-To-Outcome Design
02.
Clinical
Validation
Don’t see your exact situation?
If it involves getting a big health innovation or idea authorized, adopted, or both, evidence is still the answer — and it’s still what we do.